These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28091502)

  • 1. [Combined therapy of cerebrovascular disorders with neuroprotectors].
    Putilina MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):58-63. PubMed ID: 28091502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
    Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
    Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of the membrane-protective potential of the combination of 2-ethyl-6-methyl-3-hydroxypyridine-succinate and citicoline].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Shchelkonogov VA; Sinebryukhova AM; Farakhova KI; Sorokoumova GM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):18-22. PubMed ID: 29460900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Choice of neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions].
    Gromova OA; Torshin IY; Putilina MV; Semenov VA; Rudakov KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):42-50. PubMed ID: 32929923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citicoline: pharmacological and clinical review, 2006 update.
    Secades JJ; Lorenzo JL
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter observational program for evaluation of the effectiveness of the recognan (citicoline) in the correction of cognitive impairment in patients with chronic cerebrovascular pathology].
    Mashin VV; Belova LA; Bakhtogarimov IR; Bergelson TM; Sharafutdinova RR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):39-43. PubMed ID: 28884715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latest research in nootropic therapy of patients with chronic cerebral circulation insufficiency.
    Chernii TV; Cherniy VI; Svitlytska DV
    Wiad Lek; 2024; 77(5):1063-1068. PubMed ID: 39008598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A personalized selection of choline precursors in evidence - based medicine].
    Putilina MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):144-151. PubMed ID: 32678562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome].
    Gavrilova SI; Fedorova IaB; Gantman ; Kalyn IaB; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):16-20. PubMed ID: 22433803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
    Conant R; Schauss AG
    Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
    Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
    J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recognan (citicoline) efficacy and safety in cognitive impairment correction of various nosological forms].
    Shavlovskaya OA; Bokova IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):22-28. PubMed ID: 37994884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment].
    Fridman EA; Ottaviano F; Fiol M; Javelier A; Perea JE; Ameriso SF
    Rev Neurol; 2001 May 1-15; 32(9):818-21. PubMed ID: 11424030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citicoline preclinical and clinical update 2009-2010.
    Dávalos A; Secades J
    Stroke; 2011 Jan; 42(1 Suppl):S36-9. PubMed ID: 21164116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
    Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
    Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDP-choline as a biological supplement during neurorecovery: a focused review.
    Arenth PM; Russell KC; Ricker JH; Zafonte RD
    PM R; 2011 Jun; 3(6 Suppl 1):S123-31. PubMed ID: 21703569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.